Trial Profile
A single centre retrospective study to assess new onset or transition of disease state of psoriatic arthritis during treatment with ustekinumab.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2018
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- 31 Aug 2018 New trial record